Brief: HUTCHMED (China) Says NMPA Granted Full Approval For Orpathys (Savolitinib) In China

HUTCHMED (China)

14/01/2025 07:47

Jan 14 (Reuters) - HUTCHMED (China) Ltd  0013.HK :
    * NMPA FULL APPROVAL FOR ORPATHYS (SAVOLITINIB) IN CHINA

Source text:  ID:nHKS44VwZT 
Further company coverage:  0013.HK 

 ((Reuters.Briefs@thomsonreuters.com;))